The Kidney Institute and Division of Nephrology, China Medical University Hospital, Taichung, Taiwan.
Nephrology (Carlton). 2012 Sep;17(7):621-7. doi: 10.1111/j.1440-1797.2012.01613.x.
The long-term survival of Taiwanese children with end-stage renal disease (ESRD) has not been reported before. This study aimed to determine the long-term survival, mortality hazards and causes of death in paediatric patients receiving dialysis.
Paediatric patients (aged 19 years and younger) with incident ESRD who were reported to the Taiwan Renal Registry from 1995 to 2004 were included. A total of 319 haemodialysis (HD) and 156 peritoneal dialysis (PD) patients formed the database. After stratification by dialysis modality, multivariate Cox proportional-hazards model was constructed with age, sex and co-morbidity as predictive variables.
The annual paediatric ESRD incidence rate was 8.12 per million of age-related populations. The overall 1-, 5-, and 10-year survival rates for PD patients were 98.1%, 88.0% and 68.4%, respectively, and were 96.9%, 87.3% and 78.5% for HD patients. The survival analysis showed no significant difference between HD and PD (P = 0.4878). Using '15-19 years' as a reference group, the relative risk (RR) of the youngest group (0-4 years) was 6.60 (95% CI: 2.50-17.38) for HD, and 5.03 (95% CI: 1.23-20.67) for PD. The death rate was 24.66 per 1000 dialysis patient-years. The three major causes of death were infection (23.4%), cardiovascular disease (13.0%) and cerebrovascular disease (10.4%). Hemorrhagic stroke (87.5%) was the main type of foetal cerebrovascular accident.
We conclude that there was no significant difference of paediatric ESRD patient survival between HD and PD treatment in Taiwan. The older paediatric ESRD patients had better survival than younger patients.
此前尚未有报道过台湾地区终末期肾病(ESRD)儿童患者的长期生存情况。本研究旨在确定接受透析治疗的儿科患者的长期生存率、死亡风险和死亡原因。
本研究纳入了 1995 年至 2004 年向台湾肾脏登记处报告的年龄在 19 岁及以下的儿童 ESRD 患者。共纳入 319 名血液透析(HD)患者和 156 名腹膜透析(PD)患者作为数据库。在按透析方式分层后,采用多元 Cox 比例风险模型,以年龄、性别和合并症作为预测变量。
儿科 ESRD 的年发病率为每百万年龄相关人群 8.12 例。PD 患者的总体 1 年、5 年和 10 年生存率分别为 98.1%、88.0%和 68.4%,HD 患者分别为 96.9%、87.3%和 78.5%。生存分析显示 HD 和 PD 之间无显著差异(P=0.4878)。以“15-19 岁”为参考组,年龄最小组(0-4 岁)HD 患者的相对风险(RR)为 6.60(95%CI:2.50-17.38),PD 患者的 RR 为 5.03(95%CI:1.23-20.67)。死亡率为每 1000 例透析患者年 24.66 例。死亡的三大主要原因是感染(23.4%)、心血管疾病(13.0%)和脑血管疾病(10.4%)。出血性卒中(87.5%)是胎儿脑血管意外的主要类型。
我们的结论是,在台湾地区,HD 和 PD 治疗儿童 ESRD 患者的生存情况无显著差异。年龄较大的儿科 ESRD 患者的生存情况优于年龄较小的患者。